Bafna Pharmaceuticals Limited — Board Meeting, 26-05-2025: Outcome of Board Meeting

Bafna Pharmaceuticals has announced a board meeting on May 26, 2025, approving the financial results for the quarter and year ended March 31, 2025. The company reported revenue of ₹41.4 Cr and a profit after tax of ₹4.15 Cr for the year. Exceptional charges included inventory and asset write-offs. They are advancing the sale of their Madhavaram manufacturing unit assets. New auditors were appointed for internal, secretarial, and cost audits through FY26. Operating cash flow strengthened to ₹22.1 Cr, fueling ongoing capital investments.